These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1139 related items for PubMed ID: 27887594

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. First trimester hyperglycosylated human chorionic gonadotrophin in serum - a marker of early-onset preeclampsia.
    Keikkala E, Vuorela P, Laivuori H, Romppanen J, Heinonen S, Stenman UH.
    Placenta; 2013 Nov; 34(11):1059-65. PubMed ID: 23993394
    [Abstract] [Full Text] [Related]

  • 4. Routine first-trimester combined screening for pre-eclampsia: pregnancy-associated plasma protein-A or placental growth factor?
    Noël L, Guy GP, Jones S, Forenc K, Buck E, Papageorghiou AT, Thilaganathan B.
    Ultrasound Obstet Gynecol; 2021 Oct; 58(4):540-545. PubMed ID: 33998078
    [Abstract] [Full Text] [Related]

  • 5. Modified multiple marker aneuploidy screening as a primary screening test for preeclampsia.
    Huang T, Bedford HM, Rashid S, Rasasakaram E, Priston M, Mak-Tam E, Gibbons C, Meschino WS, Cuckle H, Mei-Dan E.
    BMC Pregnancy Childbirth; 2022 Mar 08; 22(1):190. PubMed ID: 35260099
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prediction of small-for-gestational-age neonates: screening by maternal biochemical markers at 30-34 weeks.
    Bakalis S, Gallo DM, Mendez O, Poon LC, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2015 Aug 08; 46(2):208-15. PubMed ID: 25826797
    [Abstract] [Full Text] [Related]

  • 9. Screening for trisomy at 11-13 weeks' gestation: use of pregnancy-associated plasma protein-A, placental growth factor or both.
    Mazer Zumaeta A, Wright A, Syngelaki A, Maritsa VA, Bardani E, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2020 Sep 08; 56(3):408-415. PubMed ID: 32621353
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Longitudinal changes in maternal serum placental growth factor and soluble fms-like tyrosine kinase-1 in women at increased risk of pre-eclampsia.
    Khalil A, Maiz N, Garcia-Mandujano R, Penco JM, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2016 Mar 08; 47(3):324-31. PubMed ID: 26387758
    [Abstract] [Full Text] [Related]

  • 13. Competing-risks model for prediction of small-for-gestational-age neonate from maternal characteristics, serum pregnancy-associated plasma protein-A and placental growth factor at 11-13 weeks' gestation.
    Papastefanou I, Wright D, Lolos M, Anampousi K, Mamalis M, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2021 Mar 08; 57(3):392-400. PubMed ID: 32936500
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Ultrasound features prior to 11 weeks' gestation and first-trimester maternal factors in prediction of hypertensive disorders of pregnancy.
    Hanchard TJ, de Vries BS, Quinton AE, Sinosich M, Hyett JA.
    Ultrasound Obstet Gynecol; 2020 May 08; 55(5):629-636. PubMed ID: 31909523
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Maternal serum placental growth factor (PlGF) in small for gestational age pregnancy at 11(+0) to 13(+6) weeks of gestation.
    Poon LC, Zaragoza E, Akolekar R, Anagnostopoulos E, Nicolaides KH.
    Prenat Diagn; 2008 Dec 08; 28(12):1110-5. PubMed ID: 19003787
    [Abstract] [Full Text] [Related]

  • 20. Prospective observational study to determine the accuracy of first-trimester serum biomarkers and uterine artery Dopplers in combination with maternal characteristics and arteriography for the prediction of women at risk of preeclampsia and other adverse pregnancy outcomes.
    Allen R, Aquilina J.
    J Matern Fetal Neonatal Med; 2018 Nov 08; 31(21):2789-2806. PubMed ID: 28714317
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 57.